Integer Holdings Corporation Faces Securities Fraud Class Action Lawsuit
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jan 09 2026
0mins
Source: PRnewswire
- Lawsuit Background: Between July 25, 2024, and October 22, 2025, Integer Holdings Corporation was accused of failing to disclose that it materially overstated its competitive position in the EP manufacturing market, resulting in significant investor losses.
- Sales Decline: Despite Integer's claims of strong visibility into customer demand, the company experienced a sustained deterioration in sales related to two of its EP devices, information that was not disclosed in a timely manner, impacting investor decisions.
- Misleading Statements: The company mischaracterized its EP devices as long-term growth drivers for its C&V segment, leading investors to hold positive views about the company's business and prospects that lacked a reasonable basis, exacerbating investor losses.
- Legal Action Opportunity: Affected investors must contact the Law Offices of Howard G. Smith by February 9, 2026, to participate in the class action lawsuit and protect their legal rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy ITGR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on ITGR
Wall Street analysts forecast ITGR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ITGR is 93.38 USD with a low forecast of 75.00 USD and a high forecast of 140.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
10 Analyst Rating
4 Buy
6 Hold
0 Sell
Moderate Buy
Current: 86.860
Low
75.00
Averages
93.38
High
140.00
Current: 86.860
Low
75.00
Averages
93.38
High
140.00
About ITGR
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Class Action Lawsuit Filed Against Integer Holdings Corporation
- Lawsuit Background: Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Integer Holdings Corporation on behalf of investors who purchased common stock between July 25, 2024, and October 22, 2025, alleging that the company materially overstated its competitive position in the EP manufacturing market.
- Allegation Details: The complaint alleges that despite the company's claims of strong visibility into customer demand, it was experiencing a sustained deterioration in sales of two of its EP devices, mischaracterizing them as long-term growth drivers for the C&V segment, leading to materially false and misleading statements about the company's business prospects.
- Investor Rights: Affected investors must apply by February 9, 2026, to be appointed as lead plaintiff in the lawsuit to protect their legal rights, with Bragar Eagel & Squire offering free consultations and encouraging direct contact for more information.
- Law Firm Overview: Bragar Eagel & Squire, P.C. is a nationally recognized law firm specializing in representing individual and institutional investors in securities, derivative, and commercial litigation, with extensive litigation experience and a nationwide practice.
Continue Reading
Multiple Companies Facing Class Action Lawsuits
- Bitdeer Lawsuit Overview: Bitdeer Technologies Group faces a class action lawsuit for failing to disclose the production timeline of the SEAL04 chip during the period from June 6, 2024, to November 10, 2025, which has severely undermined investor confidence in the company's prospects, potentially impacting stock performance.
- Gauzy Financial Crisis: Gauzy Ltd. is accused of failing to disclose potential insolvency risks during the period from March 11, 2025, to November 13, 2025, due to its French subsidiaries' poor financial conditions, which may lead to decreased investor trust in its debt repayment capabilities, thus affecting market performance.
- Integer Market Position Controversy: Integer Holdings Corporation is alleged to have overstated its competitive position in the EP manufacturing market from July 25, 2024, to October 22, 2025, resulting in weakened investor confidence in its sales outlook, which could negatively impact its stock price.
- F5 Security Incident Impact: F5, Inc. faces a class action lawsuit for failing to disclose a significant security incident during the period from October 28, 2024, to October 27, 2025, which poses serious risks to client trust and the company's future prospects, potentially affecting stock price stability.
Continue Reading